Home › Funds › DARK FOREST CAPITAL MANAGEMENT LP › REGN
DARK FOREST CAPITAL MANAGEMENT LP position in REGN
REGENERON PHARMACEUTICALS · Health Care
DARK FOREST CAPITAL MANAGEMENT LP reported holding 6,744 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$5.1M, representing 0.39% of its reported portfolio and ranking #26 among its reported holdings. DARK FOREST CAPITAL MANAGEMENT LP has disclosed REGN holdings in 6 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How DARK FOREST CAPITAL MANAGEMENT LP's REGN position evolved
DARK FOREST CAPITAL MANAGEMENT LP first disclosed a stake in REGN in Q3 2023 at 286 shares (US$235K). The position peaked in Q3 2026 at 6,744 shares, worth US$5.1M. Across 6 filings, DARK FOREST CAPITAL MANAGEMENT LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 6,744 shares valued at US$5.1M — an increase of 4,197 shares quarter over quarter.. Notable position changes include a 452% increase in Q2 2026 (shares rose 22% over the following quarter), a 165% increase in Q3 2026 (shares rose 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 286 | $235.37K | New |
| Q3 2024 | 635 | $667.54K | New |
| Q3 2025 | 6.07K | $3.41M | New |
| Q1 2026 | 461 | $356.19K | New |
| Q2 2026 | 2.55K | $1.59M | Add |
| Q3 2026 | 6.74K | $5.11M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About REGN and 13F data
REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include DODGE & COX (US$3.62B), Dodge & Cox (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REGN
- DODGE & COX 4.77M sh · $3.62B · Q3 2026
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- Franklin Resources 2.95M sh · $2.75B · Q3 2026
- Nuveen, LLC 1.96M sh · $1.48B · Q3 2026
- LOOMIS SAYLES & CO L P 1.72M sh · $1.30B · Q3 2026
More on DARK FOREST CAPITAL MANAGEMENT LP
FAQ
How long has DARK FOREST CAPITAL MANAGEMENT LP held REGN?
DARK FOREST CAPITAL MANAGEMENT LP has disclosed REGN holdings in 6 of the last 13 reported quarters, going back to Q3 2023.
What is DARK FOREST CAPITAL MANAGEMENT LP's current position in REGN?
As of Q3 2026, DARK FOREST CAPITAL MANAGEMENT LP holds 6.74K shares of REGN (REGENERON PHARMACEUTICALS), valued at $5.11M, representing 0.39% of its reported portfolio and ranking #26.
Has DARK FOREST CAPITAL MANAGEMENT LP been buying or selling REGN?
In the latest 13F filing (Q3 2026), DARK FOREST CAPITAL MANAGEMENT LP increased its position in REGN. The position peaked in Q3 2026 at 6.74K shares.
Which other funds hold REGN?
Other major institutional holders of REGN include DODGE & COX, Dodge & Cox, Franklin Resources, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.